Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
HESTERBIO Stock Analysis
Views
Red Flags
Positive
Moderate ROE but improving trend
Strong EPS growth and above median growth of industry
Low and declining Debt to Equity
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate and stable operating margin
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
HESTERBIO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
HESTERBIO Bulk, Block & Insider Trades
HESTERBIO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Rights issue
Bonus(1 new shares for 2 existing shares)Book closure date 29 September 2012. Ex-date: 27th Sep 2012 Announced on: 14th Aug 2012
Rights issue(2 new shares @ 70 INR for 5 existing shares)Rights issue of 1483200 securities Nominal value: Rs. 10 Premium per equity: Rs. 60 Ex-date: 29th May 2006 Announced on: 16th Nov 2005
Company Profile
Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthca... Read More
Key personnel
Dr. Bhupendra Vithaldas GandhiD
Non-Executive Chairman of the Board
Mr. Rajiv Dinesh GandhiD
Chief Executive Officer, Managing Director, Executive Director
Mr. Ashish Dineshbhai Desai
Chief Financial Officer
Mr. Vinod Mali
Compliance Officer, Company Secretary
Ms. Priya Rajiv GandhiD
Executive Director
Ms. Nina Rajiv GandhiD
Non-Executive Director
Mr. Ravin Kanti GandhiD
Non-Executive Director
Mr. Sanjiv Dinesh GandhiD
Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Hester Biosciences Ltd.?
The current share price of Hester Biosciences Ltd. is ₹ 1,559.10 as of 09 Jan 2026.
What is the PE ratio of Hester Biosciences Ltd.?
The Price-to-Earnings (PE) ratio of Hester Biosciences Ltd. is 30.33 as of the latest financial data.
What is the ROE and ROCE of Hester Biosciences Ltd.?
Hester Biosciences Ltd. has a Return on Equity (ROE) of 11.72% and a Return on Capital Employed (ROCE) of 10.19% as per the latest financial reports.
What is the market cap of Hester Biosciences Ltd.?
The market capitalization of Hester Biosciences Ltd. stands at ₹ 1,326.33 Cr.
What is the dividend yield of Hester Biosciences Ltd.?
The dividend yield of Hester Biosciences Ltd. is 0.45% based on the current market price.
What is the RSI of Hester Biosciences Ltd.?
The Relative Strength Index (RSI) of Hester Biosciences Ltd. is 40.04.
What is the FII and DII holding in Hester Biosciences Ltd.?
Foreign Institutional Investors (FII) hold 0.52% and Domestic Institutional Investors (DII) hold 0.00% of Hester Biosciences Ltd. shares.
What sector does Hester Biosciences Ltd. belong to?
Hester Biosciences Ltd. operates in the Healthcare sector.
What is the beta of Hester Biosciences Ltd. stock?
The beta of Hester Biosciences Ltd. stock is 0.81, indicating its volatility relative to the broader market.
